With the Grand Rapids Women's Expo coming up in just a few weeks, GR NFP is designing some poster displays sure to spark conversation and engagement. Below is our first design, highlighting several high-risk health side effects associated with hormonal birth control. References for each statistic are also listed.
STROKE (2-3 times more likely):
Xu, Zhenln, et al. “Current Use of Oral Contraceptives and the Risk of First-ever Ischemic Stroke: A Meta-Analysis of Observational Studies.” Thrombosis Research, 2015. doi:10.1016/j.thromres.2015.04.021.
BRAIN CANCER (Twice as likely):
Andersen, et al. “Hormonal Contraceptive Use and Risk of Glioma among Younger Women: A Nationwide Case-control Study.” British Journal of Clinical Pharmacology Br J Clin Pharmacol 79, no. 4 (2015): 677-84.
GLAUCOMA (Twice as likely):
Talsma, Julia. “Long-term Oral Contraceptive Users at Risk for Glaucoma.” American Academy of Ophthalmology, 2013.
PULMONARY EMBOLISM (Twice as likely):
Grodstein, et al. “Prospective Study of Exogenous Hormones and Risk of Pulmonary Embolism in Women.” Obstetrical & Gynecological Survey 348, no. 9033 (1996): 295-96.
BREAST CANCER (50% higher risk) & LIVER CANCER (Risk increases with duration):
“Oral Contraceptives: Combined.” IARC Monograph 72 (1999): 29-338.
HIV (Twice as likely):
Heffron, Rennee. “Use of Hormonal Contraceptives and Risk of HIV-1 Transmission: A Prospective Cohort Study.” Lancet 12, no. 1 (2012): 19-26.
CERVICAL CANCER (Twice as likely):
Moreno, Dr Victor. “Effect of Oral Contraceptives on Risk of Cervical Cancer in Women with Human Papillomavirus Infection: The IARC Multicentric Case-control Study.” Lancet 359, no. 9312 (2012): 1085-1092.
DEEP VEIN THROMBOSIS (3 times as likely):
Vinogradova, Y., et al. “Use of Combined Oral Contraceptives and Risk of Venous Thromboembolism: Nested Case-control Studies Using the QResearch and CPRD Databases.” BMJ, 2015. doi: http://dx.doi.org/10.1136/bmj.h2135